The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.

The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.

The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.

The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.

The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.

The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.

This information was originally presented on March 13, 2014, at the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

Join Anas Younes, MD, and Andrew Zelenetz, MD, PhD, as they present their multidisciplinary expertise on a range of cases pertaining to follicular lymphoma.

Join Anas Younes, MD, and Andrew Zelenetz, MD, PhD, as they present their multidisciplinary expertise on a range of cases pertaining to follicular lymphoma.

This information was originally presented on September 21, 2013, at the NCCN 8^th Annual Congress: Hematologic Malignancies™ held in New York, New York.